Publication | Open Access

A phase 1 study of the safety, reactogenicity, and immunogenicity of a Schistosoma mansoni vaccine with or without glucopyranosyl lipid A aqueous formulation (GLA-AF) in healthy adults from a non-endemic area

VaccinationSchistosoma Mansoni VaccineMucosal VaccinationVaccine DevelopmentImmunologyAqueous FormulationSchistosomiasisInfection ControlVaccine DesignImmunotherapyMedicinePhase 1Parasitology